Ultimo aggiornamento :
Stabilità e compatibilità dei farmaci
Benvenuti su Stabilis. Se desiderate ricevere la nostra newsletter trimestrale vi preghiamo di indicare il vostro indirizzo e-mail. Iscriviti

Per qualsiasi domanda o osservazione, contattare : infostab@stabilis.org
Banche di dati  
Bibliografia : 2741
Molecola : 852
Classe farmacologica : 46
Stabilità delle soluzioni : 6255
Stabilità come miscela : 1245
Compatibilità : 12258
Nome commerciale : 4979
Notizie - Molecola  
Altro Soluzione orale L-Methionine 22/05/2023
Anestetico generale Supposta Pentobarbital 22/05/2023
Antibiotico Capsula Erythromycine 22/05/2023
Antivirale Collirio Ganciclovir 02/03/2023
Ansiolitico Iniezione Remimazolam 28/02/2023
Altro Iniezione Teduglutide 24/02/2023
Altro Unguenti Resorcinol 19/01/2023
Antipertensivo Capsula Clonidine hydrochloride 05/12/2022
Antibiotico Iniezione Omadacycline 20/11/2022
Farmaco contro il cancro Iniezione Trastuzumab deruxtecan 17/11/2022
Farmaco contro il cancro Soluzione orale Vinorelbine 05/11/2022
Antibiotico Iniezione Cefradine 06/09/2022
Altro Iniezione Ambroxol 06/09/2022
Anestetico generale Iniezione Esketamine 01/09/2022
Farmaco contro il cancro Iniezione Melphalan captisol 01/09/2022
Antibiotico Iniezione Mezlocilline 01/09/2022
Farmaco contro il cancro Soluzione orale Ruxolitinib 28/06/2022
Altro Iniezione Atosiban 02/06/2022
Altro Soluzione orale Epigallocatechin gallate 02/06/2022
Ipoglicemizzante Soluzione orale Sitagliptine phosphate 02/06/2022
Notizie - Bibliografia  
Data di entrata
4747 Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease. Pharmaceutics 24/04/2023
4748 Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment. Pharmaceutics 24/04/2023
4750 Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation. Pharmaceutics 24/04/2023
4746 Stability and Compatibility of Bupivacaine and Hydromorphone in PVC and non-DEHP bags for 30 days at 4°C and 25°C. 14/04/2023
4744 Stability Report of Extended SB8 Opened Vial (400 mg) Stability. 07/04/2023
4745 Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags. Pharmaceutical Technology in Hospital Pharmacy 07/04/2023
4742 Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel 02/04/2023
4741 Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt. Int J Pharm Compound 29/03/2023
4740 MabThera 500 mg concentrate for solution for infusion. Summary of Product Characteristics Updated 07-Oct-2021 Roche Products Limited 06/03/2023
4739 Low-dose erythromycin in pediatrics: Formulation and stability of 20 mg hard gelatin capsules. PlosOne 04/03/2023
4736 An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 20/02/2023
4735 Long-term physicochemical stability of 5-fluorouracil at selected standardised rounded doses in polyolefin bags. J Oncol Pharm Practice 08/02/2023
4732 Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration. Am J Health-Syst Pharm 02/02/2023
4729 Extemporaneous Preparation of 20 mg/mL Ganciclovir in Artificial Tears in Comparison with SterileWater for Ophthalmic Administration: Formulation and Stability Study. Pharmaceutics 01/02/2023
4730 Stability of Morphine Sulfate-Clonidine and Sufentanil-Clonidine Mixtures. Neuromodulation 01/02/2023
4728 Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies. J Pharm Biomed Anal 22/01/2023
4727 Stability Study of Parenteral N-Acetylcysteine, and Chemical Inhibition of Its Dimerization Pharmaceuticals 18/01/2023
4726 Arsenic trioxide Mylan - Résumé des caractéristiques du produit Mylan 17/01/2023
4725 Tracking the physicochemical stability of teduglutide (Revestive®) clinical solutions over time in different storage containers. J Pharm Biomed Anal 10/01/2023
4723 Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration. Am J Health-Syst Pharm 21/12/2022
4724 Intravenous Physical Compatibility of Heparin Sodium and Furosemide. Int J Pharm Compound 21/12/2022
4720 Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021. Paratek Pharmaceuticals 20/11/2022
4717 Enhertu®- Résumé des caractéristiques du produit 18/11/2022
4719 Prepared omadacycline for injection: Nine-day stability and sterility in an elastomeric pump. SAGE Open Medicine 18/11/2022
4714 Etude de stabilité d'un biosimilaire du Bevacizumab dans les flacons et après dilution dans du NaCl 0.9% en poche de polyoléfine. GERPAC Congrès - octobre 2022 03/11/2022
4716 Pre-formulation and Stability Study of 20 mcg Clonidine Hydrochloride Pediatric Capsules. J Pediatr Pharmacol Ther 03/11/2022
4711 Physicochemical stability of subcutaneous daratumumab (DARZALEX® 1800 mg injection solution) in plastic syringes over a period of 28 days stored refrigerated or at room temperature. GERPAC Congrès - octobre 2022 27/10/2022
4712 Développement de formulations buvables de vinorelbine à usage pédiatrique. GERPAC Congrès - octobre 2022 27/10/2022
4710 Etude de stabilité physico-chimique du Cabazitaxel Zentiva® en flacons après "ouverture" et en solutions diluées en poches en perfusion de 3 types. GERPAC Congrès - octobre 2022 26/10/2022
4709 XERAVA® (eravacycline) for injection, for intravenous use. HIGHLIGHTS OF PRESCRIBING INFORMATION. Tetraphase Pharmaceuticals. 11/10/2022

  Mentions Légales